mohammadhossein ashraf

The subject of this research is the expression of the role of Arabic language and literature in the transfer of Islamic culture and civilization to modern Spain (Islamic Andalusia). This mapping began since 92 AH, the beginning of the Muslim presence in this land, and lasted for nearly 8 centuries. What was transferred to Andalusia as a heritage of Islamic culture and civilization during this period is in the form of written works and oral narrations, which are often translated into Arabic and its use requires the familiarity of Andalusians with this language. In this article, based on descriptive-analytical method, the main question has been what is the role of Arabic language as a bridge between Islamic culture and civilization in the East and Christian Spain in the West? According to the findings of this study, Islamic culture and civilization spread in Andalusia during the 8th century, especially in the first centuries of Islam, where almost all of its content could be transmitted in Arabic and only in this language. As a result, the Arabic language became important to both the people of Andalusia and the rulers for the transmission of religious teachings as well as the connection of Andalusians with the government. Subsequently, steps were taken to address the existing needs, such as the establishment of schools, libraries, and the transfer of scientific resources and scholars from the East to Andalusia.

This study aim to evaluate and compare type and prevalence of drug‑drug interactions (DDIs) in prescriptions dispensed in both community and hospital setting in Zabol, Iran.

A total of 2796 prescriptions were collected from community and inpatient and outpatient pharmacy of Amir‑al‑momenin only current acting hospital in Zabol, Iran. The prescriptions were processed using Lexi‑Comp drug interaction software. The identified DDIs were categorized into five classes (A, B, C, D, X).

Overall 41.6% of prescriptions had at last one potential DDI. The most common type of interactions was type C (66%). The percentage of drug interactions in community pharmacies were significantly lower than hospital pharmacies (P < 0.0001).

Our results indicate that patients in Zabol are at high risk of adverse drug reactions caused by medications due to potential DDIs. Appropriate education for physicians about potentially harmful DDIs, as well as active participation of pharmacists in detection and prevention of drug‑related injuries, could considerably prevent the consequence of DDIs among patients.

To determine the effects of recombinant human erythropoietin (rhEPO) on functional outcome and disability of patients with traumatic cervical spinal cord injury (SCI). This was a randomized, double blind, placebo controlled clinical trial being performed in Nemazee and Shahid Rajaei hospitals of Shiraz during a 3-year period from 2011 to 2014. A total number of 20 patients with acute traumatic cervical SCI less than 8 hours after injury were included. We excluded those with anatomic cord dissection, penetrating cord injury and significant concomitant injury. Patients were randomly assigned to receive rhEPO in 500IU/mL dosage immediately and 24-hour later (n=11) or placebo (n=9). All the patient received standard regimen of methylprednisolone. Neurological function was assessed on admission, 1, 6 and 12 months after the injury according to the American Spinal Cord Injury Association (ASIA). Overall we include a total number of 20 patients. The mean age of the patients was found to be 40.1 ± 9.5 (ranging from 19 to 59) years. There were 18 (90.0%) men and 2 (10.0%) women among the patients. There was no significant difference between two study groups regarding the baseline characteristics. The baseline ASIA score was comparable between two study groups. The motor and sensory ASIA scores were comparable between two study groups after 1, 6 and 12 months follow-ups. We also found that there was no significant difference between two study groups regarding the motor and sensory outcome in complete cord injury and incomplete cord injury subgroups. Administration of rhEPO does not improve the functional outcome of patients with traumatic cervical SCI.